Pretargeting for Cancer Radioimmunotherapy with Bispecific Antibodies: Role of the Bispecific Antibody's Valency for the Tumor Target Antigen
- 31 August 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 13 (5) , 1054-1070
- https://doi.org/10.1021/bc0200172
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Diagnosis of persistent ovarian carcinoma with three-step immunoscintigraphyBritish Journal of Cancer, 2000
- Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Reagent DevelopmentBioconjugate Chemistry, 1997
- Development of a Streptavidin−Anti-Carcinoembryonic Antigen Antibody, Radiolabeled Biotin Pretargeting Method for Radioimmunotherapy of Colorectal Cancer. Studies in a Human Colon Cancer Xenograft ModelBioconjugate Chemistry, 1997
- PRECLINICAL EVALUATION OF AN ANTI-TUMOR MONCLONAL ANTIBODY/ STREPTAVIDIN CONJUGATE FOR PRETARGETED 90Y RADIOIMMUNOTHERAPY IN A MOUSE XENOGRAFT MODELJournal of Immunotherapy, 1994
- Mimicry of a carcinoembryonic antigen epitope by a rat monoclonal anti‐idiotype antibodyInternational Journal of Cancer, 1994
- Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ionsAnalytical Biochemistry, 1984
- The preparation and labeling of DTPA-coupled albuminThe International Journal of Applied Radiation and Isotopes, 1982
- THE PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITYBiochemical Journal, 1963